If you’ve spent more than five minutes on the internet (so… all of us), you’ve seen the claim:
“Marijuana stops seizures.” Sometimes it’s framed as a miracle. Sometimes as a conspiracy. Sometimes as an
aunt’s friend’s cousin’s “life-changing” story. And while cannabis-related treatments can help
certain people with certain types of epilepsy, the truth is a lot less meme-friendlyand a lot more useful.

This article breaks down what we actually know about marijuana and epilepsy, what we
don’t know yet, and why the details (like the difference between CBD and THC) matter more than the
buzzwords.

Epilepsy 101: Why “Seizures” Aren’t One Thing

Epilepsy isn’t a single conditionit’s a group of neurological disorders where the brain has a tendency to
produce recurrent, unprovoked seizures. Some seizures are brief staring spells. Others involve loss of
awareness, falls, or convulsions. Different seizure types can come from different brain networks, and
epilepsy syndromes can have different causes, ages of onset, and treatment responses.

That’s why any claim that one substance “treats epilepsy” is automatically suspicious. A treatment that helps
one syndrome (or one seizure type) may do nothing for another. Good epilepsy care is a mix of accurate
diagnosis, the right anti-seizure medications, and sometimes dietary therapy, devices, or surgeryespecially
for drug-resistant epilepsy.

What “Marijuana” Means in Medical Conversations

“Marijuana” is often used as a catch-all term for the cannabis plant. In medicine and research, you’ll also
hear “cannabis” and “cannabinoids.” The plant contains many chemical compounds, but two get most of the
attention:

• THC (tetrahydrocannabinol): the main psychoactive componentthe part associated with feeling “high.”
• CBD (cannabidiol): not intoxicating in the same way, and the focus of most epilepsy research.

Here’s the big plot twist: when people say “cannabis for seizures,” the strongest evidence is not for smoked
marijuana or dispensary edibles. It’s for a purified, pharmaceutical-grade CBD product that
is regulated for consistency and safety.

The Best-Supported Option: FDA-Approved CBD (Epidiolex)

In the U.S., the headline fact is this: a prescription CBD medication exists, and it’s FDA-approved for
specific seizure syndromes. That medication is Epidiolex (cannabidiol oral solution).

Which epilepsies does Epidiolex treat?

Epidiolex is approved to treat seizures associated with:

• Dravet syndrome
• Lennox-Gastaut syndrome (LGS)
• Tuberous sclerosis complex (TSC)

These are often severe, treatment-resistant syndromes. In clinical trials, adding purified CBD to a patient’s
existing regimen reduced seizure frequency more than placebo for these conditions. That’s a big deal in a
field where many families are used to hearing, “We’ve tried everything.”

Why “pharmaceutical-grade” matters

Epidiolex is standardizedeach dose contains a consistent concentration of CBD and is manufactured with
quality controls. This is the opposite of “artisanal CBD oil,” which may vary bottle to bottle (or even
dropper to dropper). If your brain is prone to seizures, “surprise ingredients” is not a fun lifestyle choice.

What About Non-Prescription CBD and Medical Marijuana?

This is where the conversation gets messybecause public access has expanded faster than the science (and in
many places, faster than product regulation).

Over-the-counter CBD: promising concept, uneven reality

Hemp-derived CBD products are widely sold, but many are not evaluated by the FDA for seizure treatment.
Independent testing studies have found that online CBD products can be inaccurately labeledmeaning the CBD
content may be higher or lower than advertised, and some products may contain THC even when it’s not listed.

For someone with epilepsy, inconsistent dosing can mean inconsistent effects. And if a product contains THC
unexpectedly, it may raise additional risksespecially for teens, people sensitive to psychoactive effects,
or anyone who needs to avoid impairment.

Medical marijuana: a different substance than purified CBD

“Medical marijuana” products typically include varying ratios of THC and CBD, along with other cannabinoids.
The scientific evidence for cannabis itself (as opposed to purified CBD) in epilepsy is still
limited. Some people report benefits, but anecdotal reports can be misleadingespecially in a condition where
seizure frequency naturally waxes and wanes, and where changes in sleep, stress, hormones, and medication
adherence can all shift outcomes.

Translation: a person can start cannabis, have fewer seizures for a month, and sincerely credit the cannabis
even if the change was due to a different factor. That doesn’t mean they’re lying. It means epilepsy is
complicated and the brain doesn’t care about our timelines.

How CBD May Work in the Brain (Without the Hand-Waving)

Scientists are still mapping the exact mechanisms, but CBD appears to influence multiple signaling systems
involved in neuronal excitability. Rather than acting like a single “on/off” switch, CBD likely works through
a mix of receptor and ion channel effects that can reduce the brain’s tendency to enter hyper-excitable
states.

Importantly, CBD is not a universal “calm button.” It may help certain seizure networks more than others,
which aligns with why evidence is strongest for specific syndromes.

Safety: The Part That Shouldn’t Be Skipped

When people talk about marijuana and epilepsy online, the conversation often jumps straight to “Does it
work?” A better question is: Does it work safely for this person, with their medications, at their
age, with their risks?

Common side effects seen with prescription CBD

In clinical trials of purified CBD, commonly reported side effects included:

• Sleepiness or fatigue
• GI symptoms (like diarrhea or decreased appetite)
• Elevated liver enzymes in some patients (a signal your clinician takes seriously)

The FDA has also warned that CBD can cause liver injury and can interact with other medications, potentially
changing how they work in the body. This is why medical supervision and monitoring matter.

Drug interactions: where epilepsy care gets real

Many anti-seizure medications are metabolized in the liver. CBD can alter enzyme activity and interact with
certain drugs. Two well-known examples in epilepsy care:

• Clobazam: CBD can increase levels of an active clobazam metabolite in some people, which
  can worsen sedation.
• Valproate: Using CBD with valproate has been associated with a higher risk of elevated
  liver enzymes in some patients, prompting closer monitoring.

None of this means CBD is “bad.” It means it’s a real medication-like substance, not a decorative plant vibe.
If you’re adding anythingprescription CBD, dispensary products, supplementsto an epilepsy regimen, the
neurologist should know. This is not the time for “surprise, I’m DIY-ing neuropharmacology.”

Teens and young adults: extra caution, not extra shame

People sometimes forget that “marijuana” isn’t just a medical topic; it’s also a brain development topic.
Public health guidance notes that teen brains are still developing into the mid-20s, and cannabis use in
youth has been linked to problems with attention, learning, and mental healthincluding a stronger
association with psychosis-like experiences in those who start earlier and use more frequently.

If you’re a teen with epilepsy, or a caregiver reading for one, the safest framing is:
any cannabis-related product should be discussed with a clinician, and medical decisions
should prioritize seizure safety, mental health, and medication interactionsnot trends.

Quality Control: The “What’s Actually in the Bottle?” Problem

Epilepsy treatment depends on consistency. That’s why FDA-approved drugs come with standardized doses and
manufacturing controls. Many non-prescription CBD products don’t.

Research analyzing CBD products sold online found frequent mismatches between labeled and actual contents.
For epilepsy, that raises three practical concerns:

1. Unpredictable dosing (making benefits and side effects harder to anticipate).
2. Unexpected THC exposure (which may cause impairment or unwanted psychoactive effects).
3. Contaminants (such as residual solvents or other impurities, depending on manufacturing quality).

If a clinician recommends cannabis-related therapy, they usually emphasize regulated products and
medical follow-up for a reason: it’s not about being anti-cannabis. It’s about being pro-not-getting-hurt.

Legality and Labels: Hemp, Marijuana, and the Patchwork Problem

U.S. cannabis policy can feel like it was designed by a committee of squirrels on espresso. Here’s the
practical takeaway: federal law, state law, and product regulation don’t always align.
Hemp and hemp-derived products have a legal definition under federal law, but the rules for what’s sold,
what’s tested, and what claims can be made vary widely by stateand the landscape keeps evolving.

For epilepsy families, this patchwork often creates a frustrating gap: people can buy products marketed for
health, while still lacking reliable guidance on quality and medical oversight. When in doubt, default to
the boring-but-effective strategy: involve the treating neurologist and use regulated options when possible.

So… Should Someone With Epilepsy Try Marijuana or CBD?

The most accurate answer is: it dependsand anyone who promises you otherwise is selling
something (a product, a narrative, or an ego).

Situations where CBD has the strongest evidence

Pharmaceutical-grade CBD has strong evidence as an add-on treatment for seizures in Dravet syndrome,
Lennox-Gastaut syndrome, and tuberous sclerosis complex.

Situations where caution is especially important

• If the person is a teen or young adult (brain development and mental health risks matter).
• If they take medications that may interact with CBD (common in epilepsy care).
• If the only available option is an unregulated product with unclear contents.
• If there’s a history of mood disorders, psychosis, or severe anxiety.

Questions worth asking a neurologist

If cannabis-related therapy is on the table, these questions tend to move the conversation from “internet
debate” to “actual care”:

• Which seizure type or syndrome are we treatingand is CBD supported for it?
• Could my current anti-seizure medications interact with cannabidiol?
• Would prescription CBD (like Epidiolex) be appropriate, and would monitoring be needed?
• What side effects should we watch for, and what labs (if any) should be checked?
• What other evidence-based options should we make sure we’ve considered first?

Experiences: What People Report (And What Clinicians Often Notice)

Clinical trials give us averages. Real life gives us storiesmessy, emotional, and full of context. The
following experiences are drawn from common themes reported by patients, caregivers, and clinicians (not a
substitute for medical advice, and not proof that a product will work for any one person). Still, these
patterns can help you understand why the cannabis-and-epilepsy conversation feels so charged.

1) The “We tried everything” familyand the relief of a measurable change

Caregivers of children with severe syndromes like Dravet or LGS often describe a long, exhausting timeline:
medication after medication, emergency visits, sleepless nights, and the constant fear that the next seizure
will be the one that changes everything. When prescription CBD is added and seizure counts dropeven
modestlymany families say the biggest benefit isn’t just fewer seizures. It’s fewer crises. Fewer ambulance
calls. More predictable days. Sometimes the child’s alertness and engagement improve simply because the brain
is spending less time in seizure states or recovering from them.

But families also describe the “fine print” that rarely goes viral: dose adjustments, lab monitoring,
side-effect troubleshooting (especially sleepiness or appetite changes), and careful coordination with other
anti-seizure medications. In other words, the wins often come from a medical process, not a magic potion.

2) The adult with focal seizures who tries a dispensary productand gets mixed results

Adults with focal epilepsy sometimes experiment (especially in states with legal access) after hearing
success stories. A common report is inconsistency: one product seems helpful for sleep and stress (both of
which can influence seizure risk), another seems to do nothing, and another causes unpleasant cognitive
effects. Some people stop because they feel foggy, anxious, or “not themselves.” Others feel calmer but can’t
tell whether seizures truly changed or whether life simply got a little less stressful.

Clinicians often point out an unglamorous truth here: if the product’s CBD/THC content isn’t reliably
standardized, it’s hard to learn anything from the experimentbecause the “treatment” keeps changing.
People can walk away thinking “cannabis doesn’t work,” when the real issue is, “We never tested a consistent
compound in a consistent way.”

3) The “it helped… until it didn’t” phase

Another theme is a promising early period followed by plateau or disappointment. This can happen with many
epilepsy treatments, not just cannabis-related ones. Seizure patterns fluctuate naturally. Puberty, sleep
disruption, illness, missed doses, medication metabolism changes, and stress can all alter seizure control.
So when someone reports, “CBD helped for three months and then stopped,” it doesn’t automatically mean CBD
“failed.” It may mean the epilepsy changed, another trigger emerged, or the broader treatment plan needs
adjustment.

Some families describe a turning point when their care team shifts from “find one miracle” to “build a
layered plan”medication optimization, rescue therapy strategy, sleep support, and safety planning. In those
stories, CBD may remain one useful tool, but not the entire toolbox.

4) The teen or young adult navigating epilepsy plus mental health

Teens with epilepsy often carry more than seizure riskthey may also be dealing with anxiety, depression,
social stress, and medication side effects. In that context, cannabis can show up as a tempting “shortcut”
for sleep or stress relief. The experiences people report here are all over the map: some feel temporarily
calmer; others feel more anxious, paranoid, or emotionally unsettled. For those prone to panic or mood
symptoms, THC-heavy products are commonly described as a bad match.

The healthiest real-world pattern is the one that looks the least dramatic: the teen talks with a caregiver,
the neurologist is brought in, mental health is taken seriously, and any cannabis-related therapy is handled
as a medical decisionnot a secret experiment. The goal isn’t to moralize. The goal is to protect a
developing brain while also treating a serious neurological condition.

Across these experiences, one theme stands out: the best outcomes tend to happen when cannabis-related care
is integrated into epilepsy treatmentdocumented, monitored, and adjustedrather than treated
as an off-the-books workaround.

Conclusion: Evidence First, Hype Last

Marijuana and epilepsy is not a yes-or-no story. It’s a “which compound, which product, which epilepsy
syndrome, and which risks” story. The strongest evidence supports pharmaceutical-grade CBD
(Epidiolex) as an add-on therapy for Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex.
Outside those lanes, the science is still developingand unregulated products add a serious layer of
uncertainty.

If you’re considering CBD or medical cannabis for seizures, treat it like what it is: a medical decision
that deserves medical supervision. The goal is fewer seizures and a better lifenot a viral before-and-after
clip with missing context.

SEO tags

The post Marijuana and Epilepsy appeared first on Quotes Today.

CBD oil has had one of the fastest glow-ups in modern wellness history. A few years ago, it was “that hemp thing.”
Now it’s in tinctures, gummies, lotions, seltzers, pet treats, bath bombs, andif someone could figure out a wayprobably in printer ink.
The vibe is always the same: natural, plant-based, gentle, ancient remedy. The label practically whispers,
“Don’t worry, I’m a leaf.”

Here’s the problem: “natural” is not a safety certification. Poison ivy is natural. So are rattlesnakes.
And while CBD (short for cannabidiol) isn’t out here plotting your downfall, it can still cause side effects, interact with medications,
and come with quality-control issues that make buying it feel like a game of “Supplement Roulette.”

This article breaks down what we actually know about CBD oil safety, why the “it’s natural so it’s fine” logic falls apart,
and how to think like a cautious grown-up (even if your CBD gummy is shaped like a smiling bear).

What CBD oil is (and what it isn’t)

CBD vs. THC vs. hempseed oil: the confusion is real

CBD is a chemical compound found in cannabis plants. It’s often sourced from hemp (a type of cannabis legally defined in the U.S. by low THC content),
and it does not cause the classic “high” associated with THC (tetrahydrocannabinol). That distinction is why CBD became the
“respectable cousin” in many wellness aisles.

But labels can be misleading. “Hemp oil” might mean hempseed oil (a culinary oil with little to no CBD),
while “full-spectrum CBD” might mean CBD plus other cannabinoidsincluding small amounts of THC. And sometimes,
“CBD-like” products can contain intoxicating cannabinoids that consumers didn’t intend to buy.

The one CBD product the FDA actually approved

In the U.S., the FDA has approved one prescription CBD medication: Epidiolex, used for certain rare seizure disorders.
That matters because it shows CBD can be a real medicine in a controlled contextbut also because the safety data we have is strongest for
pharmaceutical CBD monitored by clinicians, not for the endless variety of over-the-counter oils, gummies, vapes, and drinks.

Why “natural” doesn’t equal “safe” for CBD oil

1) CBD can cause side effects (even when it’s “just a supplement”)

Many people tolerate CBD without major issues, but “often tolerated” is not the same thing as “risk-free.”
Reported side effects can include drowsiness or fatigue, dry mouth, diarrhea, and appetite changes.
Some people also report feeling foggy or slowed downgreat if you’re trying to sleep, not great if you’re trying to drive, study,
or do anything requiring a functioning attention span.

The effects can also depend on dose, product type, individual metabolism, and what else is in the product
(including other cannabinoids or additives). Translation: two people can take “CBD oil” and have very different experiences,
because “CBD oil” is not one standardized thing.

2) CBD can interact with medications (sometimes in big ways)

This is one of the most important safety pointsand one of the least sexy for marketing.
CBD can affect how the body processes certain medications, which may change how strong those medications are in your system.
That can increase side effects or reduce effectiveness, depending on the drug.

A common example mentioned in clinical guidance is interaction concern with medications such as some blood thinners.
There are also cautions around combining CBD with substances that cause sedation (including alcohol and certain anxiety or sleep medications),
because stacking “sleepy effects” can raise the risk of impairment and accidents.

If you take prescription meds, have chronic conditions, or are under medical care for anything more complicated than a papercut,
CBD is not a “just try it” situation. It’s a “talk to a clinician or pharmacist first” situation.

3) Liver safety: the part nobody puts on the front label

Another big reason “natural” doesn’t equal “safe”: CBD has been associated with liver enzyme elevations in some settings,
particularly at higher doses used in research and in prescription contexts. The FDA has warned about the potential for liver injury with CBD,
and other health agencies have also highlighted liver toxicity as a potential risk.

To be clear, not every person who uses CBD will have liver problems, and dose appears to matter.
But liver risk is exactly the kind of safety detail that gets lost when CBD is treated like a harmless wellness accessory.
If you already have liver disease, drink heavily, or take medications that affect the liver, the “just a plant” storyline can become
“just a problem.”

4) Product quality is inconsistent: you may not be getting what you think

Here’s the uncomfortable truth about the U.S. CBD marketplace: a lot of products are mislabeled.
Multiple analyses of commercially available CBD products have found that labeled CBD amounts often don’t match what’s in the package.
That means you might be taking less CBD than you think (and feeling nothing), or more than you think (and feeling side effects),
or something else entirely.

Even more concerning, some products marketed as CBD have been found to contain THC or other cannabinoids not clearly disclosed.
That matters for safety, for impairment risk, for workplace drug testing, and for anyone who is deliberately avoiding intoxicating substances.

5) Contaminants happen: heavy metals, pesticides, solvents, and “surprise ingredients”

Cannabis plants can absorb substances from soil and the growing environment. If cultivation and manufacturing aren’t carefully controlled,
products can potentially include contaminants like heavy metals, pesticide residues, or residual solvents from extraction.
Some recent product testing studies have reported detection of heavy metals across a sample of CBD products,
alongside potency and labeling problems.

This is not a reason to panic-buy a bunker full of “CBD-free” air. It’s a reason to understand that safety depends not just on CBD as a molecule,
but on how a product is made, tested, stored, and labeled.

Who should be especially careful with CBD oil

People who take prescription medications

Because of drug interaction potential, anyone on prescriptionsespecially medications with narrow safety marginsshould get professional input first.
Pharmacists are particularly good at spotting interaction risks because it’s basically their superhero origin story.

People with liver conditions or risk factors

If you have known liver disease, abnormal liver labs, heavy alcohol use, or take other substances that stress the liver,
CBD is not a casual add-on. It should be discussed with a clinician who can evaluate risk.

Pregnant or breastfeeding people

The data on CBD use during pregnancy and breastfeeding is limited, and major health bodies generally urge caution with cannabis-derived products
during these periods. “Limited data” doesn’t mean “probably fine.” It means “we don’t know enough to call it safe.”

Children and households with young kids

Child exposures are a real-world safety issueespecially with gummies and sweetened products that look like candy.
Poison control organizations advise storing CBD products out of reach and contacting Poison Help immediately for exposures or adverse reactions.
Separate but related: some “CBD-like” products have been confused with or converted into intoxicating cannabinoids (like delta-8 THC),
which increases risk when labeling is unclear.

Older adults

Older adults are more likely to take multiple medications and may be more sensitive to sedation, dizziness, or blood pressure changes.
If CBD makes you sleepy or unsteady, falls become the enemy, and falls do not care that your tincture is “artisan.”

Common red flags in CBD marketing

“Cures everything” claims

If a CBD product claims it can cure cancer, reverse Alzheimer’s, fix your metabolism, and make your ex regret leaving…
that’s not wellness. That’s a red flag wearing a trench coat. Be skeptical of medical claims, especially when they’re sweeping,
dramatic, and not supported by rigorous evidence.

Vague labels and missing testing info

“Proprietary blend” is sometimes marketing-speak for “please don’t ask what’s in here.”
Lack of clear ingredient lists, no batch identification, or no accessible third-party testing information
are all signs you’re buying faith, not verified quality.

Confusing cannabinoid language

Terms like “full-spectrum,” “broad-spectrum,” and “isolate” can be meaningful, but they’re also used loosely.
If you don’t want THC exposure, unclear labeling becomes a safety issuenot just a preference issue.

How to think about CBD oil safety like a responsible adult

Start with your goal and your risk profile

People use CBD for many reasonspain, sleep, anxiety, inflammation, general “I heard it helps” curiosity.
But the smarter starting question is: What am I trying to accomplish, and what could go wrong for me specifically?
If you take medications, have medical conditions, or are in a sensitive life stage (pregnancy, breastfeeding),
your risk profile is different than someone who is otherwise healthy.

Loop in a clinician when it matters

A clinician can’t magically guarantee a supplement product is perfectbut they can help you evaluate interactions,
side effects, and whether CBD makes sense given your health history. This is especially important if you’re using CBD
alongside prescription treatments. CBD should not replace evidence-based care without medical guidance.

Respect impairment risk

If CBD makes you drowsy, slowed down, dizzy, or mentally cloudy, treat it like something that can impair you.
Avoid driving or risky activities until you know how your body reacts.
And don’t “stack sedatives” with alcohol or other substances that can increase drowsiness.

Remember that “more” isn’t automatically “better”

One reason mislabeled products are risky is that they can push people into unintended higher exposure.
Higher doses in research settings have been more strongly associated with lab abnormalities like liver enzyme elevations.
This is why standardization mattersand why the “it’s just a supplement” mindset can backfire.

Real-World Experiences: What people actually run into (about )

If you want to understand why “natural doesn’t mean safe” matters, skip the influencer captions and look at what tends to happen in real life.
Not the cinematic version where one dropper of CBD oil fixes someone’s entire personality. The real versionmessy, inconsistent,
and full of “wait, why do I feel like this?”

One common experience is the unexpected nap. Someone buys CBD oil for “calm focus” and then discovers their calm is actually
“I could sleep through a marching band.” Drowsiness doesn’t sound dramatic, but it becomes a safety issue when it hits at the wrong time:
before driving, while supervising kids, or during a workday that requires basic alertness. People often assume a non-intoxicating product
can’t impair them. Then they learn the difference between “not high” and “not fully functional.”

Another frequent storyline is the mystery reaction. A person tries a new CBD gummy and gets stomach upset, diarrhea, or a weird
mix of fatigue and jitteriness. Was it CBD? Was it another cannabinoid? Was it an additive, sweetener, or contaminant? With inconsistent labeling,
it’s not always obvious. This uncertainty is part of the safety problem: when products aren’t standardized, it’s harder to pinpoint what caused
the reactionand harder to avoid it next time.

Then there’s the medication collision. Someone who takes a prescription (for example, something that affects blood clotting,
seizures, mood, or sleep) adds CBD because it’s “natural.” A week later they feel offmore side effects, extra sedation, or changes in how their
medication seems to work. They don’t always connect it to CBD until a clinician asks, “Any supplements?” and they say, “Oh… just CBD.”
The key word in that sentence is just. CBD is biologically active, and that’s the whole pointso it deserves the same disclosure
as any other substance you ingest regularly.

A particularly stressful experience is the surprise THC problem. Some people use CBD specifically because they want to avoid THC,
impairment, or workplace testing issues. But product testing research has repeatedly found mislabeling and unexpected cannabinoid content.
The real-world result: someone feels more altered than expected, fails a drug test, or worries they did something “wrong” when the product
simply didn’t match the label. That’s not a moral failing. It’s a quality-control failure.

Finally, there’s the kid-in-the-candy-aisle scenario. In homes where gummies or flavored oils are stored like vitamins,
young children may get into them because they look and taste like candy. Poison control groups emphasize safe storage and quick action after exposure
because these situations happeneven in careful households. If a product is marketed like a treat, people will treat it like a treat,
and kids will treat it like a mission.

None of these experiences mean CBD is automatically dangerous for everyone. They mean CBD is not automatically safe simply because it’s natural.
The safest mindset is not “CBD is bad” or “CBD is magic.” It’s: CBD is an active compound in a messy marketplace.
Treat it with the same respect you’d give anything that can change how your body feels.

Conclusion

CBD oil sits at a weird intersection of medicine, supplements, and marketingwhere “plant-based” sometimes gets mistaken for “harmless.”
But CBD can cause side effects, interact with medications, and pose risks when products are mislabeled or contaminated.
The core takeaway is simple: natural does not mean safe.

If you’re considering CBD, prioritize your specific health situation, talk to a qualified clinician when medications or medical conditions are involved,
and be extra cautious about product quality and labeling. The goal isn’t fear. The goal is informed, realistic decision-making
the kind that doesn’t rely on vibes as a safety standard.

The post CBD oil: Natural does not mean it is safe appeared first on Quotes Today.